Changes in cerebral function parameters in HIV-1 infected subjects undergoing a treatment simplification to darunavir/ritonavir

7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK

Saved in:
Bibliographic Details
Published inJournal of the International AIDS Society Vol. 13; no. Suppl 4; p. P52
Main Authors Garvey, LJ, Higgs, C, Mohammed, P, Nelson, M, Winston, A
Format Journal Article
LanguageEnglish
Published London BioMed Central 01.11.2010
The International AIDS Society
John Wiley & Sons, Inc
Subjects
Antiretroviral drugs
Antiviral drugs
Brain diseases
Cognition disorders
Complications and side effects
Darunavir
Drug therapy
HIV infection
Indexing in process
Infectious Diseases
Medicine
Medicine & Public Health
Poster Presentation
Public Health
Risk factors
Ritonavir
Virology
United Kingdom
Nucleoside Analogue
Proton Spectroscopy
Cerebral Metabolite
Cerebral Function
Metabolite Marker
Online AccessGet full text
ISSN1758-2652
1758-2652
DOI10.1186/1758-2652-13-S4-P52

Cover

More Information
Summary:7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:1758-2652
1758-2652
DOI:10.1186/1758-2652-13-S4-P52